Point Mutants of c-Raf-1 RBD with Elevated Binding to v-Ha-Ras

• Published in: The Journal of biological chemistry 2000-09, Vol.275 (39), p.30363-30371
• Main Authors: Fridman, Masha, Maruta, Hiroshi, Gonez, Jorge, Walker, Francesca, Treutlein, Herbert, Zeng, Jun, Burgess, Antony
• Format: Article
• Language: English
• Subjects: Amino Acid Sequence; Binding Sites - genetics; DNA Mutational Analysis; Models, Molecular; Molecular Sequence Data; Point Mutation; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary - genetics; Proto-Oncogene Proteins c-raf - genetics; Proto-Oncogene Proteins c-raf - metabolism; ras Proteins - metabolism; Sequence Homology, Amino Acid
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M003193200

A mutational analysis of the Ras-binding domain (RBD) of c-Raf-1 identified three amino acid positions (Asn64, Ala85, and Val88) where amino acid substitution with basic residues increases the binding of RBD to recombinant v-Ha-Ras. The greatest increase in binding (6–9-fold) was observed with the A85K-RBD mutant. The elevated binding for the A85K-RBD and V88R-RBD mutants was also detected with Ras expressed in cultured mammalian cells, namely NIH-3T3 and BAF cells. None of the wild type residues in RBD positions Asn64, Ala85, and Val88 have been previously implicated in the interaction with Ras (Block, C., Janknecht, R., Herrmann, C., Nassar, N., and Wittinghofer, A. (1996)Nat. Struct. Biol. 3, 244–251; Nassar, N., Horn, G., Herrmann, C., Scherer, A., McCormick, F., and Wittinghofer, A. (1995)Nature 375, 554–560). The discovery of elevated binding among the mutants in these positions implies that additional RBD residues can be used to generate the Ras·RBD complex. These findings are of particular significance in the design of Ras antagonists based on the RBD prototype. The A85K-RBD mutant can be used to develop an assay for measuring the level of activated Ras in cultured cells; Sepharose-linked A85K-RBD·GST fusion protein served as an activation-specific probe to precipitate Ras·GTP but not Ras·GDP from epidermal growth factor-stimulated cells. A85K-RBD precipitates up to 5-fold more Ras·GTP from mammalian cells than wild type RBD.